메뉴 건너뛰기




Volumn 39, Issue 12, 2012, Pages 1076-1077

Sorafenib-induced psoriasis and hand-foot skin reaction responded dramatically to systemic narrowband ultraviolet B phototherapy

Author keywords

[No Author keywords available]

Indexed keywords

EMOLLIENT AGENT; SORAFENIB; UREA;

EID: 84870243798     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2012.01615.x     Document Type: Letter
Times cited : (12)

References (6)
  • 1
    • 33846212284 scopus 로고    scopus 로고
    • Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
    • Liu L, Cao Y, Chen C, et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 2006; 66: 11851-11858.
    • (2006) Cancer Res , vol.66 , pp. 11851-11858
    • Liu, L.1    Cao, Y.2    Chen, C.3
  • 2
    • 70350238222 scopus 로고    scopus 로고
    • National Cancer Institute Available at (Accessed February 10, 2012)
    • National Cancer Institute. Common terminology criteria for adverse events v4.0 (CTCAE). Available at: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010- 06-14-QuickReference-5x7.pdf (Accessed February 10, 2012).
    • Common Terminology Criteria for Adverse Events v4.0 (CTCAE)
  • 3
    • 77949894522 scopus 로고    scopus 로고
    • Sorafenib-induced psoriasiform eruption in a patient with metastatic thyroid carcinoma
    • Diamantis ML, Chon SY,. Sorafenib-induced psoriasiform eruption in a patient with metastatic thyroid carcinoma. J Drugs Dermatol 2010; 9: 169-171.
    • (2010) J Drugs Dermatol , vol.9 , pp. 169-171
    • Diamantis, M.L.1    Chon, S.Y.2
  • 4
    • 38349177232 scopus 로고    scopus 로고
    • Functional characterization of CD4+CD25+ regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriasis patients with a family history of the disorder
    • Zhang K, Li X, Yin G, et al. Functional characterization of CD4+CD25+ regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriasis patients with a family history of the disorder. Br J Dermatol 2008; 158: 298-305.
    • (2008) Br J Dermatol , vol.158 , pp. 298-305
    • Zhang, K.1    Li, X.2    Yin, G.3
  • 5
    • 79961125367 scopus 로고    scopus 로고
    • Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients
    • Desar IM, Jacobs JFM, Hulsbergen-vandeKaa CA, et al. Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients. Int J Cancer 2011; 129: 507-512.
    • (2011) Int J Cancer , vol.129 , pp. 507-512
    • Desar, I.M.1    Jacobs, J.F.M.2    Hulsbergen-Vandekaa, C.A.3
  • 6
    • 77649195502 scopus 로고    scopus 로고
    • Sorafenib-associated remission of psoriasis in hypernephroma: Case report
    • Fournier C, Tisman G,. Sorafenib-associated remission of psoriasis in hypernephroma: case report. Dermatol Online J 2010; 16: 17.
    • (2010) Dermatol Online J , vol.16 , pp. 17
    • Fournier, C.1    Tisman, G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.